Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 65

The DOI matches its Crossref record.

Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis

Zemanick, Edith T., Emerson, Julia, Thompson, Valeria, McNamara, Sharon, Morgan, Wayne, Gibson, Ronald L., Rosenfeld, Margaret, the EPIC Study Group·2015·Pediatric Pulmonology

Abstract

Summary: Objectives: To evaluate clinical outcomes associated with initial isolation of Pseudomonas aeruginosa ( Pa ) in a large U.S. cystic fibrosis (CF) cohort in the current era of widespread early Pa eradication therapy. Methods: Participants were children with CF enrolled in the Early Pseudomonas Infection Control (EPIC) Observational Study who had no isolation of Pa from respiratory cultures prior to enrollment. Population‐averaged regression models using generalized estimating equation methods were used to estimate the effect of Pa acquisition on endpoints including lung function, growth, pulmonary exacerbation rate, respiratory signs and symptoms, and respiratory cultures. Results: Eight hundred thirty‐eight subjects were observed for a mean 4.6 (SD 1.2) years during which 431 (51%) acquired Pa . There was no statistically significant effect of Pa acquisition on the slopes of FEV 1 % predicted or growth parameters. Pulmonary exacerbation rate was statistically significantly greater after Pa acquisition (incident rate ratio 1.40, 95% CI 1.07, 1.84) as were odds of crackles or wheeze on physical exam (OR 1.23, 95% CI 1.00, 1.52). Odds of isolation of MRSA (OR 1.86, 95% CI 1.38, 2.49) and S. maltophilia (OR 2.11, 95% CI 1.49, 2.98) increased after Pa acquisition, while the odds of H. influenzae (OR 0.54, 95% CI 0.46, 0.64) decreased. Conclusions: In this large U.S. cohort, we did not detect an association between acquisition of Pa and deterioration in lung function or nutrition. Pa acquisition was associated with significantly increased pulmonary exacerbation rate and odds of crackles or wheeze. Pa infection may be the cause of these outcomes or a marker of more severe disease. Pediatr Pulmonol. 2015; 50:42–48. © 2014 The Authors. Pediatric Pulmonology Published by Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ppul.23036

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. 10.1164/rccm.200304-505SO · DOI · Paper page
  2. 10.1001/jama.293.5.581 · DOI · Paper page
  3. 10.1016/j.jpeds.2007.03.006 · DOI · Paper page
  4. 10.1002/ppul.1950120306 · DOI · Paper page
  5. 10.1097/00063198-200311000-00008 · DOI
  6. 10.1016/j.jcf.2012.10.004 · DOI · Paper page
  7. 10.1016/j.jcf.2009.03.001 · doi:10.1016/j.jcf.2009.03.001
  8. 10.1016/S0022-3476(09)90007-5 · DOI
  9. 10.1002/ppul.2009 · doi:10.1002/ppul.2009
  10. 10.1002/ppul.10127 · DOI · Paper page
  11. 10.1164/rccm.200710-1599OC · DOI
  12. 10.1002/ppul.21417 · doi:10.1002/ppul.21417
  13. 10.1016/j.jcf.2012.04.003 · doi:10.1016/j.jcf.2012.04.003
  14. 10.1016/j.cct.2009.01.003 · DOI
  15. 10.1016/j.jpeds.2008.05.005 · DOI · Paper page
  16. 10.1002/ppul.1950150204 · DOI · Paper page
  17. Kuczmarski RJ, 2002, CDC Growth Charts for the United States: methods and development, Vital Health Stat, 11, 1
  18. 10.1164/ajrccm/148.6_Pt_1.1502 · DOI
  19. 10.1164/ajrccm.159.1.9712108 · DOI · Paper page
  20. 10.1002/ppul.21374 · DOI · Paper page
  21. 10.1002/ppul.21525 · DOI
  22. 10.1001/archpediatrics.2011.136 · DOI · Paper page
  23. 10.1002/ppul.22693 · DOI
  24. 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V · doi:10.1002/(sici)1099-0496(199911)28:5<321::aid-ppul3>3.0.co;2-v

Cited by

See all 65

Metadata

Authors
Zemanick, E. T., Emerson, J., Thompson, V., McNamara, S., Morgan, W., Gibson, R. L., Rosenfeld, M., & the EPIC Study Group
Venue
Pediatric Pulmonology
Publisher
Wiley
Published
2014-03-18
Volume
50
Issue
1
Pages
42-48
ISSN
  • 8755-6863
  • 1099-0496
Cited by
65
References
0
Language
en
Funders
  • Cystic Fibrosis Foundation Grants (OBSERV04K0, EPIC0K0)
  • Clinical Trials Registration (NCT00097773)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. https://app.cochat.ai/papers/10.1002/ppul.23036
The paper
Zemanick, E. T., Emerson, J., Thompson, V., McNamara, S., Morgan, W., Gibson, R. L., Rosenfeld, M., & the EPIC Study Group. (2015). Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.23036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.